IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Arch Venture Management, LLC

Q4 2018 Holdings

Filed 2019-02-14 | 6 holdings | $100.0K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2019-05-17) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Rubius Therapeutics IncCOM78116T103$42.1K2,618,35142.1%
Fate Therapeutics Inc(FATE)COM31189P102$26.6K2,073,19026.6%
Kura Oncology Inc(KURA)COM50127T109$26.1K1,856,30726.1%
Chiasma Inc(CHMA)COM16706W102$3.7K1,196,7763.7%
Bellerophon Therapeutics, Inc(BLPHEUR)ACOM078771102$774965,6600.8%
Achaogen IncCOM004449104$768624,5440.8%